A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis
- 31 December 2002
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 47 (6), 821-833
- https://doi.org/10.1067/mjd.2002.127247